Processa Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | |||
EBITDA | -3,376 | -3,358 | -3,436 |
EBIT | -3,377 | -3,358 | -3,436 |
Net Income | -3,377 | -3,358 | -3,436 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -3,590 | -2,900 | -3,484 |
Cash | 1,691 | 5,536 | 6,308 |
Basic Shares | 2,623 | 2,571 | 1,901 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | -874 | ||
EBITDA | -13,562 | -11,849 | -11,121 | -26,635 |
EBIT | -13,563 | -11,850 | -11,121 | -27,424 |
Net Income | -13,563 | -11,850 | -11,121 | -27,424 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,385 | -11,248 | -8,066 | -9,605 |
Cash | 5,536 | 1,191 | 4,706 | 6,503 |
Basic Shares | 1,309 | 122 | 52 | 32 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.19 |
2025-09-30 | -$1.75 |
2025-06-30 | -$0.25 |
2025-03-31 | -$7.50 |